4-ANILINO-3-QUINOLINECARBONITRILES FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)

摘要

The claimed invention is directed to a method of treating, inhibiting, or preventing acute myelogenous leukemia, also called acute myeloid leukemia (AML), using 4-anilino-3-quinolinecarbonitriles.